Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.
The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...
1. Verfasser: | Hobbs, F |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2003
|
Ähnliche Einträge
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
von: article Editorial
Veröffentlicht: (2020-09-01) -
Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
von: Hobbs, R, et al.
Veröffentlicht: (2005) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
von: Alberto J Lorenzatti, et al.
Veröffentlicht: (2020-02-01) -
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
von: Mach, F, et al.
Veröffentlicht: (2019) -
Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
von: Meor Anuar Shuhaili, Meor Fairuz Rizal, et al.
Veröffentlicht: (2018)